Robert T. Brooke
Chief Executive Officer at Intervene Immune, Inc.
Profile
Robert T.
Brooke is the founder of four companies.
He founded Range Impact, Inc. in 2007, Iovance Biotherapeutics, Inc. in 2007, Percipio Biosciences, Inc. in 2008, and Intervene Immune, Inc. in 2014.
At Range Impact, Inc., he held the titles of CEO, Treasurer & Director from 2014 to 2019.
At Iovance Biotherapeutics, Inc., he was the President & Chief Executive Officer from 2007 to 2011.
At Percipio Biosciences, Inc., he was the President from 2008 to 2013.
At Intervene Immune, Inc., he is currently the Chief Executive Officer & Chief Technology Officer.
Mr. Brooke's current job is as a Member at Gerontology Research Group.
Mr. Brooke received his graduate degree from the University of California, Los Angeles in 2005 and his undergraduate degree from Georgia Institute of Technology in 2003.
Robert T. Brooke active positions
| Companies | Position | Start |
|---|---|---|
| Gerontology Research Group | Corporate Officer/Principal | 08/04/2010 |
Intervene Immune, Inc.
 Intervene Immune, Inc. BiotechnologyHealth Technology Intervene Immune, Inc. develops biotechnological products. It specializes in reversing thymic involution. The company was founded by Greg Fahy and Robert T. Brooke in March 2014 and is headquartered in Manhattan Beach, CA. | Chief Executive Officer | 01/03/2014 |
Former positions of Robert T. Brooke
| Companies | Position | End |
|---|---|---|
| RANGE IMPACT, INC. | Chief Executive Officer | 08/05/2019 |
Percipio Biosciences, Inc.
 Percipio Biosciences, Inc. Medical SpecialtiesHealth Technology Percipio Biosciences, Inc. manufactures and distributes products related to oxidative stress research. The company supplies Bioxytech kits, antibodies, enzymes and other products allowing IHC, western blotting and HPLC analysis of other key biomarkers.Its line of oxidative biomarker test kits includes assays for lipid, protein and DNA determinants of oxidative mediated damage.The company was founded by Robert T. Brooke and is headquartered in Foster City, CA. | Founder | 01/06/2013 |
| IOVANCE BIOTHERAPEUTICS, INC. | Chief Executive Officer | 11/02/2011 |
| Genesis Biopharma, Inc. /Old/ | President | 06/04/2010 |
| Bristol Investment Fund Ltd | Corporate Officer/Principal | 01/01/2008 |
Training of Robert T. Brooke
| University of California, Los Angeles | Graduate Degree |
| Georgia Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
| RANGE IMPACT, INC. | Health Technology |
| Private companies | 6 |
|---|---|
| Genesis Biopharma, Inc. /Old/ | Health Technology |
| Gerontology Research Group | |
Intervene Immune, Inc.
Intervene Immune, Inc. BiotechnologyHealth Technology Intervene Immune, Inc. develops biotechnological products. It specializes in reversing thymic involution. The company was founded by Greg Fahy and Robert T. Brooke in March 2014 and is headquartered in Manhattan Beach, CA. | Health Technology |
Percipio Biosciences, Inc.
Percipio Biosciences, Inc. Medical SpecialtiesHealth Technology Percipio Biosciences, Inc. manufactures and distributes products related to oxidative stress research. The company supplies Bioxytech kits, antibodies, enzymes and other products allowing IHC, western blotting and HPLC analysis of other key biomarkers.Its line of oxidative biomarker test kits includes assays for lipid, protein and DNA determinants of oxidative mediated damage.The company was founded by Robert T. Brooke and is headquartered in Foster City, CA. | Health Technology |
| Bristol Investment Fund Ltd | Miscellaneous |
Vitality Healthtech, Inc.
 Vitality Healthtech, Inc. Pharmaceuticals: OtherHealth Technology Vitality Healthtech, Inc. develops healthcare treatments and operates specialty healthcare centres. It focus on the use of cannabinoid therapies. The company is headquartered in Los Angeles, CA. | Health Technology |
- Stock Market
- Insiders
- Robert T. Brooke
